Treating mice with sodium selenite (SS), a GPX4 activator, reversed this effect by promoting cell survival, reducing the appearance of NASH on histology, improving AST and ALT, and inflammatory cytokine levels. This evidence concerns the gene GPX4 and metabolic dysfunction-associated steatohepatitis.